The global PCR Molecular Diagnostics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淧CR Molecular Diagnostics Industry Forecast鈥� looks at past sales and reviews total world PCR Molecular Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected PCR Molecular Diagnostics sales for 2025 through 2031. With PCR Molecular Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PCR Molecular Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global PCR Molecular Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on PCR Molecular Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global PCR Molecular Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PCR Molecular Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PCR Molecular Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of PCR Molecular Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
PCR Molecular Diagnostic Instrument
PCR Molecular Diagnostic Reagents
PCR Molecular Diagnostic Consumables
Segmentation by Application:
Infectious Disease Testing
Tumor Testing
Dna Testing
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
bioMereieux SA
Danaher Corporation
Bio-Rad Laboratories
QIAGEN N.V
F-Hoffmann-La Roche Ltd.
Genomic Health
GRIFOLS S.A
Thermo Fisher Scientific Inc.
Seegene Inc.
Hologic Inc.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global PCR Molecular Diagnostics 麻豆原创 Size (2020-2031)
2.1.2 PCR Molecular Diagnostics 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for PCR Molecular Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 PCR Molecular Diagnostics Segment by Type
2.2.1 PCR Molecular Diagnostic Instrument
2.2.2 PCR Molecular Diagnostic Reagents
2.2.3 PCR Molecular Diagnostic Consumables
2.3 PCR Molecular Diagnostics 麻豆原创 Size by Type
2.3.1 PCR Molecular Diagnostics 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global PCR Molecular Diagnostics 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 PCR Molecular Diagnostics Segment by Application
2.4.1 Infectious Disease Testing
2.4.2 Tumor Testing
2.4.3 Dna Testing
2.4.4 Others
2.5 PCR Molecular Diagnostics 麻豆原创 Size by Application
2.5.1 PCR Molecular Diagnostics 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global PCR Molecular Diagnostics 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 PCR Molecular Diagnostics 麻豆原创 Size by Player
3.1 PCR Molecular Diagnostics 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global PCR Molecular Diagnostics Revenue by Player (2020-2025)
3.1.2 Global PCR Molecular Diagnostics Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global PCR Molecular Diagnostics Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PCR Molecular Diagnostics by Region
4.1 PCR Molecular Diagnostics 麻豆原创 Size by Region (2020-2025)
4.2 Global PCR Molecular Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas PCR Molecular Diagnostics 麻豆原创 Size Growth (2020-2025)
4.4 APAC PCR Molecular Diagnostics 麻豆原创 Size Growth (2020-2025)
4.5 Europe PCR Molecular Diagnostics 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa PCR Molecular Diagnostics 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas PCR Molecular Diagnostics 麻豆原创 Size by Country (2020-2025)
5.2 Americas PCR Molecular Diagnostics 麻豆原创 Size by Type (2020-2025)
5.3 Americas PCR Molecular Diagnostics 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PCR Molecular Diagnostics 麻豆原创 Size by Region (2020-2025)
6.2 APAC PCR Molecular Diagnostics 麻豆原创 Size by Type (2020-2025)
6.3 APAC PCR Molecular Diagnostics 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe PCR Molecular Diagnostics 麻豆原创 Size by Country (2020-2025)
7.2 Europe PCR Molecular Diagnostics 麻豆原创 Size by Type (2020-2025)
7.3 Europe PCR Molecular Diagnostics 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa PCR Molecular Diagnostics by Region (2020-2025)
8.2 Middle East & Africa PCR Molecular Diagnostics 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa PCR Molecular Diagnostics 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global PCR Molecular Diagnostics 麻豆原创 Forecast
10.1 Global PCR Molecular Diagnostics Forecast by Region (2026-2031)
10.1.1 Global PCR Molecular Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas PCR Molecular Diagnostics Forecast
10.1.3 APAC PCR Molecular Diagnostics Forecast
10.1.4 Europe PCR Molecular Diagnostics Forecast
10.1.5 Middle East & Africa PCR Molecular Diagnostics Forecast
10.2 Americas PCR Molecular Diagnostics Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 PCR Molecular Diagnostics Forecast
10.2.2 Canada 麻豆原创 PCR Molecular Diagnostics Forecast
10.2.3 Mexico 麻豆原创 PCR Molecular Diagnostics Forecast
10.2.4 Brazil 麻豆原创 PCR Molecular Diagnostics Forecast
10.3 APAC PCR Molecular Diagnostics Forecast by Region (2026-2031)
10.3.1 China PCR Molecular Diagnostics 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 PCR Molecular Diagnostics Forecast
10.3.3 Korea 麻豆原创 PCR Molecular Diagnostics Forecast
10.3.4 Southeast Asia 麻豆原创 PCR Molecular Diagnostics Forecast
10.3.5 India 麻豆原创 PCR Molecular Diagnostics Forecast
10.3.6 Australia 麻豆原创 PCR Molecular Diagnostics Forecast
10.4 Europe PCR Molecular Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 PCR Molecular Diagnostics Forecast
10.4.2 France 麻豆原创 PCR Molecular Diagnostics Forecast
10.4.3 UK 麻豆原创 PCR Molecular Diagnostics Forecast
10.4.4 Italy 麻豆原创 PCR Molecular Diagnostics Forecast
10.4.5 Russia 麻豆原创 PCR Molecular Diagnostics Forecast
10.5 Middle East & Africa PCR Molecular Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 PCR Molecular Diagnostics Forecast
10.5.2 South Africa 麻豆原创 PCR Molecular Diagnostics Forecast
10.5.3 Israel 麻豆原创 PCR Molecular Diagnostics Forecast
10.5.4 Turkey 麻豆原创 PCR Molecular Diagnostics Forecast
10.6 Global PCR Molecular Diagnostics Forecast by Type (2026-2031)
10.7 Global PCR Molecular Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 PCR Molecular Diagnostics Forecast
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories PCR Molecular Diagnostics Product Offered
11.1.3 Abbott Laboratories PCR Molecular Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 bioMereieux SA
11.2.1 bioMereieux SA Company Information
11.2.2 bioMereieux SA PCR Molecular Diagnostics Product Offered
11.2.3 bioMereieux SA PCR Molecular Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 bioMereieux SA Main Business Overview
11.2.5 bioMereieux SA Latest Developments
11.3 Danaher Corporation
11.3.1 Danaher Corporation Company Information
11.3.2 Danaher Corporation PCR Molecular Diagnostics Product Offered
11.3.3 Danaher Corporation PCR Molecular Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Danaher Corporation Main Business Overview
11.3.5 Danaher Corporation Latest Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Information
11.4.2 Bio-Rad Laboratories PCR Molecular Diagnostics Product Offered
11.4.3 Bio-Rad Laboratories PCR Molecular Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Bio-Rad Laboratories Main Business Overview
11.4.5 Bio-Rad Laboratories Latest Developments
11.5 QIAGEN N.V
11.5.1 QIAGEN N.V Company Information
11.5.2 QIAGEN N.V PCR Molecular Diagnostics Product Offered
11.5.3 QIAGEN N.V PCR Molecular Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 QIAGEN N.V Main Business Overview
11.5.5 QIAGEN N.V Latest Developments
11.6 F-Hoffmann-La Roche Ltd.
11.6.1 F-Hoffmann-La Roche Ltd. Company Information
11.6.2 F-Hoffmann-La Roche Ltd. PCR Molecular Diagnostics Product Offered
11.6.3 F-Hoffmann-La Roche Ltd. PCR Molecular Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 F-Hoffmann-La Roche Ltd. Main Business Overview
11.6.5 F-Hoffmann-La Roche Ltd. Latest Developments
11.7 Genomic Health
11.7.1 Genomic Health Company Information
11.7.2 Genomic Health PCR Molecular Diagnostics Product Offered
11.7.3 Genomic Health PCR Molecular Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Genomic Health Main Business Overview
11.7.5 Genomic Health Latest Developments
11.8 GRIFOLS S.A
11.8.1 GRIFOLS S.A Company Information
11.8.2 GRIFOLS S.A PCR Molecular Diagnostics Product Offered
11.8.3 GRIFOLS S.A PCR Molecular Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 GRIFOLS S.A Main Business Overview
11.8.5 GRIFOLS S.A Latest Developments
11.9 Thermo Fisher Scientific Inc.
11.9.1 Thermo Fisher Scientific Inc. Company Information
11.9.2 Thermo Fisher Scientific Inc. PCR Molecular Diagnostics Product Offered
11.9.3 Thermo Fisher Scientific Inc. PCR Molecular Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Thermo Fisher Scientific Inc. Main Business Overview
11.9.5 Thermo Fisher Scientific Inc. Latest Developments
11.10 Seegene Inc.
11.10.1 Seegene Inc. Company Information
11.10.2 Seegene Inc. PCR Molecular Diagnostics Product Offered
11.10.3 Seegene Inc. PCR Molecular Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Seegene Inc. Main Business Overview
11.10.5 Seegene Inc. Latest Developments
11.11 Hologic Inc.
11.11.1 Hologic Inc. Company Information
11.11.2 Hologic Inc. PCR Molecular Diagnostics Product Offered
11.11.3 Hologic Inc. PCR Molecular Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Hologic Inc. Main Business Overview
11.11.5 Hologic Inc. Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
